Google Searches for Thyroid Eye Disease After Regulatory Approval of Teprotumumab.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2022.1000
Abstract: Importance Given that direct-to-consumer advertising campaigns have the potential to both positively and negatively affect patient care, clinicians would benefit from being conscious of changes in public interest that result from such campaigns. Objective To… read more here.
Keywords: thyroid eye; teprotumumab; eye disease; search ... See more keywords
Teprotumumab for Graves’ orbitopathy and ototoxicity: moving problems from eyes to ears?
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-022-01791-w
Abstract: Graves’ orbitopathy (GO) is an autoimmune orbital disease mostly associated with Graves’ hyperthyroidism, causing disfiguring signs (exophthalmos, periorbital swelling, strabismus) and relevant symptoms (diplopia, tearing, photophobia, and [rarely] sight loss) [1]. While the majority of… read more here.
Keywords: two randomized; teprotumumab; drug; randomized clinical ... See more keywords
A Paradigm Shift in the Management of Thyroid Eye Disease How Teprotumumab Has Changed the Therapeutic Interface
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neuro-Ophthalmology"
DOI: 10.1097/wno.0000000000001515
Abstract: Supplemental Digital Content is Available in the Text. Background: Teprotumumab, a monoclonal antibody that blocks the insulin-like growth factor-1 receptor, has recently been approved by the US Food and Drug Administration (FDA) for the treatment… read more here.
Keywords: disease; thyroid eye; teprotumumab; management ... See more keywords
Teprotumumab in thyroid eye disease: wonder drug or great divider?
Sign Up to like & getrecommendations! Published in 2023 at "European thyroid journal"
DOI: 10.1530/etj-23-0043
Abstract: Progress in management of thyroid eye disease (TED) has been slow for many decades. The recent introduction of teprotumumab (TEP) in the therapeutic arena for TED has had a major impact in view of its… read more here.
Keywords: thyroid; thyroid eye; teprotumumab; eye disease ... See more keywords
Effect of teprotumumab on intraocular pressure in thyroid-associated ophthalmopathy
Sign Up to like & getrecommendations! Published in 2022 at "Taiwan Journal of Ophthalmology"
DOI: 10.4103/tjo.tjo_30_22
Abstract: PURPOSE: To examine changes in intraocular pressure (IOP) in patients with thyroid eye disease (TED) following teprotumumab. MATERIALS AND METHODS: A retrospective review of 17 patients with TED who received teprotumumab between January 2020 and… read more here.
Keywords: weeks weeks; teprotumumab; iop; intraocular pressure ... See more keywords
Novel teprotumumab treatment of severe thyroid dermopathy; ototoxicity as an adverse side effect.
Sign Up to like & getrecommendations! Published in 2023 at "Dermatology online journal"
DOI: 10.5070/d329160211
Abstract: Pretibial myxedema, more generally thyroid dermopathy, results from mucopolysaccharide accumulation in the dermis, typically between the knee and dorsal foot. Thyroid dermopathy presents in Graves disease, but can occur in Hashimoto thyroiditis, primary hypothyroidism, and… read more here.
Keywords: thyroid dermopathy; effect; thyroid; teprotumumab ... See more keywords